RxDoctor Payments Data

Sharad Mansukani

Ophthalmology · Moorestown, NJNPI 1386980175

Payments from drug & device makers

What this record shows

The money is spread across several categories — ownership interests (32.2%), consulting fees and other — rather than concentrated in one kind of arrangement. Reporting peaked in 2019 at $447,701 and has fallen 67.3% since, to $146,484 in 2023. Among ophthalmology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$744,356in general payments, 2019–2025

Across 54 payments — averaging $13,784 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Endo Pharmaceuticals Inc.$408K
  • Immucor, Inc.$336K

What the payments were for

  • Consulting fees$207,12028%
  • Speaking & faculty fees$120,00016%
  • Travel & lodging$45,2916%
  • Food & beverage$2,5810%
  • Ownership interest$240,00032%
  • Other$129,36417%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Endo Pharmaceuticals Inc.47$407,872
Immucor, Inc.7$336,484

How this compares

$744,356 in reported general payments places this provider in the 95th percentile of 583 ophthalmology providers in New Jersey.

See all ophthalmology providers in New Jersey →

Other ophthalmology in Moorestown

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →